T1	Participants 111 143	growth hormone-deficient adults]
T2	Participants 251 296	patients with growth hormone deficiency (GHD)
T3	Participants 497 531	bone quality in patients with GHD.
T4	Participants 553 627	20 adult patients with GHD (eleven male, nine female, mean age 42.5 years)
T5	Participants 750 774	all patients received GH
T6	Participants 834 878	patients were followed for another 72 months
T7	Participants 901 967	patients were compared to 20 age- und sex-matched healthy controls
